Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease ; volume:9 ; number:1 ; day:16 ; month:3 ; year:2017 ; pages:1-14 ; date:12.2017
Alzheimer's research & therapy ; 9, Heft 1 (16.3.2017), 1-14, 12.2017
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Lee, Spencer A. W.
- Beteiligte Personen und Organisationen
-
Sposato, Luciano A.
Hachinski, Vladimir
Cipriano, Lauren E.
SpringerLink (Online service)
- DOI
-
10.1186/s13195-017-0243-0
- URN
-
urn:nbn:de:1111-201704062939
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Spencer A. W.
- Sposato, Luciano A.
- Hachinski, Vladimir
- Cipriano, Lauren E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Biomarkers in Alzheimer’s disease
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Biomarkers in Alzheimer’s disease
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics
Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer’s disease
Cerebrospinal Fluid S100B and Alzheimer’s Disease Biomarkers in Hip Fracture Patients with Delirium
Biomarkers in Alzheimer’s disease
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease